GNCC Capital, Inc.

    Jurisdiction
    United States
    LEI
    5493007Y8619GXCC1D47
    ISIN
    US38013E2037 (GNCP)
    Sectors
    1. Basic Materials
    2. Gold

    Scores

    Fair value (Benjamin Graham formula)
    N/A

    Profile

    GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. Read full profile

    Fundamentals

    No data available

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications